|
ZMIZ1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.357200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.732400E-01 |
| Normal-vs-Stage2 |
1.451640E-01 |
| Normal-vs-Stage3 |
2.926400E-01 |
| Normal-vs-Stage4 |
3.560100E-02 |
| Stage1-vs-Stage2 |
4.942000E-01 |
| Stage1-vs-Stage3 |
5.143400E-01 |
| Stage1-vs-Stage4 |
1.602590E-01 |
| Stage2-vs-Stage3 |
9.047800E-01 |
| Stage2-vs-Stage4 |
1.749150E-01 |
| Stage3-vs-Stage4 |
4.203000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.750200E-02 |
| Normal-vs-AfricanAmerican |
8.024200E-01 |
| Normal-vs-Asian |
9.147400E-01 |
| Caucasian-vs-AfricanAmerican |
3.103200E-01 |
| Caucasian-vs-Asian |
7.804000E-01 |
| AfricanAmerican-vs-Asian |
9.447000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.423700E-02 |
| Normal-vs-Female |
8.107800E-01 |
| Male-vs-Female |
1.563430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.566200E-01 |
| Normal-vs-Extreme_Weight |
2.370000E-01 |
| Normal-vs-Obese |
4.185400E-01 |
| Normal-vs-Extreme_Obese |
8.540400E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.640200E-01 |
| Normal_Weight-vs-Obese |
6.360400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.232400E-01 |
| Extreme_Weight-vs-Obese |
7.390600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.635400E-01 |
| Obese-vs-Extreme_Obese |
3.828400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.843600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.907200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.480700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.819700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.573600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.087620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.024500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.820600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.613500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.184600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.996000E-01 |
| Normal-VS-Type2 PRCC |
9.56140000000216E-05 |
| Normal-VS-KIRP CIMP |
1.069520E-02 |
| Normal-VS-Unclassified PRCC |
8.162600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.95070000000142E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.116220E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.923600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.541200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.659600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.068840E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.214770E-04 |
| Normal-vs-N1 |
1.744280E-02 |
| Normal-vs-N2 |
7.320600E-01 |
| N0-vs-N1 |
8.960600E-01 |
| N0-vs-N2 |
2.988400E-01 |
| N1-vs-N2 |
4.995000E-01 |
|
|
